LED Medical Diagnostics Inc. reported earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, net loss before tax was USD 1,447,713 as compared to a net loss of USD 855,484 for the three months ended September 30, 2016. The net loss for the three months ended September 30, 2017 was largely due to a significant decrease in the fair market value of the company's Canadian dollar denominated warrants as well as losses resulting from normal business operations. The decrease in the fair market value of the Canadian dollar warrants is an accounting adjustment with no impact on cash flow. The company reported revenue of USD 3.2 million, which is a decrease of 14% from the three months ended June 30, 2017 and a 28% increase from the three months ended September 30, 2016. Cash flow used in operations was USD 2.7 million during the nine months ended September 30, 2017 compared to USD 1.8 million during the nine months ended September 30, 2016.